Blume Capital Management, Inc.

Position in ABCL — AbCellera Biologics Inc.

CIK 1587192 BERKELEY, CA

Position in ABCL

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$9,772

+$196 QoQ

Shares Held

2,800

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Blume Capital Management, Inc. holds $12,202 across 3 Biotechnology names. ABCL ranks #1 (80.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABCL	AbCellera Biologics Inc. This page	2,800	$9,772
2	MRNA	Moderna, Inc.	45	$2,286
3	INO	Inovio Pharmaceuticals, Inc.	83	$144

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,772	2,800	0.0%	Shares	Sole	2026-05-01
2025-12-31	$9,576	2,800	+33.3%	Shares	Sole	2026-02-05
2025-09-30	$10,563	2,100	—	Shares	Sole	2025-11-06
No filing history on record for this holder in this stock.